Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $32.2000 (1.35%) ($31.3200 - $32.8400) on Tue. Apr. 3, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.6% (three month average) | RSI | 20 | Latest Price | $32.2000(1.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.5% a day on average for past five trading days. | Weekly Trend | EDIT declines -9.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(63%) XBI(61%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -2.3% in a week (0% probabilities). VIXM(-12%) TLT(-5%) SHY(-5%) GDXJ(-5%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.3% (StdDev 4.6%) | Hourly BBV | 0 () | Intraday Trend | 0.5% | | | |
|
1 - 5 Day Possible Target | $16.7(-48.14%) | Resistance Level | $37.77 | 5 Day Moving Average | $32.59(-1.2%) | 10 Day Moving Average | $35.1(-8.26%) | 20 Day Moving Average | $37.77(-14.75%) | To recent high | -27% | To recent low | 7.9% | Market Cap | $2b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |